Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
111.8 CHF | -1.06% | -4.77% | +8.54% |
Nov. 30 | Medacta to Expand Swiss Facilities to Boost Production Capacity | MT |
Oct. 30 | Medacta Group to Launch Optimized Knee Implant | MT |
Business Summary
Number of employees : 1,631
Sales per Business
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Hip
46.6
%
| 194 | 49.4 % | 204 | 46.6 % | +5.48% |
Knee
37.6
%
| 142 | 36.1 % | 165 | 37.6 % | +16.57% |
Spine
9.5
%
| 37 | 9.3 % | 42 | 9.5 % | +14.17% |
Shoulder
6.0
%
| 20 | 5.1 % | 26 | 6.0 % | +32.51% |
Sportsmed
0.3
%
| 1 | 0.2 % | 1 | 0.3 % | +104.08% |
Sales per region
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Europe
32.6
%
| 128 | 32.6 % | 143 | 32.6 % | +11.99% |
United States
31.1
%
| 117 | 29.9 % | 137 | 31.1 % | +16.55% |
Australia
12.4
%
| 55 | 13.9 % | 54 | 12.4 % | -0.94% |
Switzerland
10.2
%
| 41 | 10.5 % | 45 | 10.2 % | +9.02% |
Asia Pacific
9.2
%
| 37 | 9.4 % | 41 | 9.2 % | +9.37% |
Rest of World
4.3
%
| 14 | 3.5 % | 19 | 4.3 % | +37.52% |
North America
0.2
%
| 1 | 0.2 % | 1 | 0.2 % | -17.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 2018 | |
Corrado Farsetta
DFI | Director of Finance/CFO | 55 | 2007 |
Gianluca Olgiati
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Riccardo Braglia
BRD | Director/Board Member | 63 | 2020 |
Director/Board Member | 66 | 2018 | |
Philippe Weber
BRD | Director/Board Member | 58 | 2018 |
Alberto Siccardi
FOU | Founder | 79 | 1998 |
Director/Board Member | 48 | 2017 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,000,000 | 6,022,590 ( 30.11 %) | 42,482 ( 0.2124 %) | 30.11 % |
Company contact information

Group companies
Name | Category and Sector |
---|---|
Medacta International SA
|
Health Technology - Medical Specialties
|
Sector
Sales per Business
Sales per region
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
119.62EUR
Average target price
137.58EUR
Spread / Average Target
+15.02%
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.54% | 2 577 M $ | |
-4.95% | 181 B $ | |
+1.42% | 105 B $ | |
-8.14% | 67 437 M $ | |
+3.50% | 45 283 M $ | |
+22.94% | 40 545 M $ | |
+30.89% | 38 230 M $ | |
+45.94% | 25 413 M $ | |
-9.16% | 24 204 M $ | |
+27.18% | 23 483 M $ |
- Stock
- Equities
- Stock Medacta Group SA - Swiss Exchange
- Company Medacta Group SA